This study tests a new gene therapy for adults with classic congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. The treatment delivers a working copy of the CYP21A2 gene using a harmless virus. Researchers aim to see if it is safe and can r…
Phase: PHASE1, PHASE2 • Sponsor: Adrenas Therapeutics Inc • Aim: Disease control
Last updated May 14, 2026 12:03 UTC